Dwight Owen
Clinical trials sponsored by Dwight Owen, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for advanced lung cancer: drug combo trial launches Results expected Dec 2026 (estimated)
-
New combo attack on stubborn cancers shows promise in early trial
Disease control CompletedThis phase II trial tests whether combining the immunotherapy drug nivolumab with the chemotherapy drug temozolomide can shrink tumors in people with small-cell lung cancer that has returned or not responded to treatment, or advanced neuroendocrine tumors. About 55 participants w…
Phase 2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Vitamin a derivative combined with immunotherapy shows promise in early lung cancer trial
Disease control CompletedThis early-phase trial is testing a combination of all-trans retinoic acid (ATRA), a substance made from vitamin A, and the immunotherapy drug atezolizumab in people with advanced non-small cell lung cancer that has spread or come back. The main goal is to find the safest dose an…
Phase 1 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC